Drug Discovery World: The next generation of cancer therapies revealed at AACR 2026

In an AACR 2026 roundup, Drug Discovery World highlights emerging therapeutic strategies shaping the next generation of cancer treatment, including induced proximity therapeutics, next generation antibody-drug conjugates, and expanding applications of AI across drug discovery. The article underscores both the scientific momentum behind targeting historically “undruggable” targets and the funding headwinds facing oncology innovation, offering perspective on where differentiated platforms and clinically validated mechanisms are attracting attention despite a constrained capital environment. Notably, the roundup features Pheast’s own AACR presentation, highlighting initial Phase 1a clinical data for PHST001 alongside new preclinical combination findings.

Read the full article here.